BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
December 19, 2019 12:00 ET | Bio-Reference Laboratories
Elmwood Park, NJ, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and...
BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders
November 04, 2019 08:00 ET | Bio-Reference Laboratories
Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division,...
BIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER BY THE IPA ASSOCIATION OF AMERICA
August 01, 2019 08:00 ET | Bio-Reference Laboratories
Elmwood Par, NJ, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA...
BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers
July 01, 2019 08:00 ET | Bio-Reference Laboratories
MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been...
BioReference Laboratories Supports Man Cave Health During National Men’s Health Month
June 07, 2019 07:00 ET | Bio-Reference Laboratories
ELMWOOD PARK, N.J., June 07, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave...
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories
May 17, 2019 08:30 ET | Bio-Reference Laboratories
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of...
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions
May 02, 2019 17:05 ET | Bio-Reference Laboratories
Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...
BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019
April 17, 2019 11:32 ET | Bio-Reference Laboratories
ELMWOOD PARK, NJ, April 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it has been recognized by Forbes as one of America’s...
BioReference Laboratories Supports Federal Employees Amidst Government Shutdown
January 28, 2019 07:30 ET | Bio-Reference Laboratories
Elmwood Park, New Jersey, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories Inc., an OPKO Health Company (NASDAQ: OPK), today announced that they will offer flexible payment arrangements...